Wells Fargo
LHDX

Wells Fargo’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Wells Fargo’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,109
Closed -$1.12K – 7869
2022
Q4 		$1.12K Sell
10,109
-497
-5% -$317 ﹤0.01% 6147
2022
Q3 		$11K Sell
10,606
-3,958
-27% -$9.02K ﹤0.01% 5672
2022
Q2 		$27K Sell
14,564
-10,644
-42% -$25.9K ﹤0.01% 5309
2022
Q1 		$90K Sell
25,208
-55,179
-69% -$271K ﹤0.01% 5381
2021
Q4 		$692K Sell
80,387
-494
-0.6% -$3.14K ﹤0.01% 4412
2021
Q3 		$614K Sell
80,881
-273
-0.3% -$2.3K ﹤0.01% 4543
2021
Q2 		$538K Buy
81,154
+63,665
+364% +$401K ﹤0.01% 4579
2021
Q1 		$211K Buy
+17,489
New +$347K ﹤0.01% 5127

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return